We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PGEN market cap is 353.47M. The company's latest EPS is USD -0.3853 and P/E is -3.69.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 16.72M | 1.76M | 1.85M | 1.77M | 1.38M |
| Operating Income | -6.75M | -22.43M | -23.48M | -21.12M | -20.94M |
| Net Income | 87.38M | -22.18M | -22.73M | -20.32M | -19.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 90.72M | 103.18M | 103.87M | 26.91M | 6.23M |
| Operating Income | -206.09M | -87.74M | -79.32M | -74.86M | -99.31M |
| Net Income | -322.32M | -170.52M | -92.17M | 28.32M | -95.9M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 259.25M | 215.98M | 241.55M | 207.53M | 190.69M |
| Total Liabilities | 116.71M | 89.72M | 57.41M | 41.32M | 43.01M |
| Total Equity | 142.53M | 126.26M | 184.13M | 166.21M | 147.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 455.76M | 314.59M | 359.86M | 215.98M | 151.04M |
| Total Liabilities | 384.05M | 247.41M | 252.51M | 89.72M | 32.55M |
| Total Equity | 71.71M | 67.17M | 107.35M | 126.26M | 118.5M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -49.65M | -65.05M | -18.39M | -34.16M | -51.16M |
| Investing | 215M | 226.42M | -50.41M | -26.91M | -16.38M |
| Financing | -116.01M | -155.29M | 44.17M | 29.59M | 29.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -135.93M | -77.02M | -55.77M | -65.05M | -66.93M |
| Investing | 86.85M | 27.78M | -74.54M | 226.42M | -3.09M |
| Financing | 8.14M | 32.71M | 121.19M | -155.29M | 29.59M |
| Market Cap | 353.47M |
| Price to Earnings Ratio | -3.69 |
| Price to Sales Ratio | 56.8 |
| Price to Cash Ratio | 46.71 |
| Price to Book Ratio | 2.98 |
| Dividend Yield | - |
| Shares Outstanding | 248.92M |
| Average Volume (1 week) | 817.48k |
| Average Volume (1 Month) | 769.27k |
| 52 Week Change | 23.48% |
| 52 Week High | 1.8799 |
| 52 Week Low | 0.8354 |
| Spread (Intraday) | 0.24 (14.91%) |
| Company Name | Precigen Inc |
| Address |
4701 cox road glen allen, virginia 23060 |
| Website | https://www.dna.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
